Showing results (191-200 of 1,160) with videos related to
Sort By:
Pageof 116
Journal of Leukocyte Biology|June 20, 2007
Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cellsDongying Cui, Edward Thorp, Yankun Li, et al.Plos One|May 13, 2021
Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosisLale Ozcan, Canan Kasikara, Arif Yurdagul, et al.Science Translational Medicine|July 24, 2010
Could exercise metabolomics pave the way for gymnomimetics?Megan F Burke, Richard L Dunbar, Daniel J RaderCirculation Research|June 7, 2014
Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndromeRobert S Rosenson, H Bryan Brewer, Daniel J RaderEuropean Heart Journal. Cardiovascular Pharmacotherapy|September 22, 2022
RNA-targeted therapeutics in cardiovascular disease: the time is nowKonstantin A Krychtiuk, Daniel J Rader, Christopher B GrangerBiochemical Society Transactions|October 31, 2015
Tribbles-1: a novel regulator of hepatic lipid metabolism in humansRobert C Bauer, Batuhan O Yenilmez, Daniel J RaderEndocrinology|May 22, 2002
Perspective: cardiovascular disease in the postgenomic era--lessons learned and challenges aheadJonathan A Epstein, Daniel J Rader, Michael S ParmacekThe Journal of Biological Chemistry|June 29, 2010
Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertasesJun Liu, Huq Afroza, Daniel J Rader, et al.Clinical Lipidology|April 17, 2012
Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategiesSadik H Kassim, James M Wilson, Daniel J RaderCurrent Opinion in Lipidology|February 12, 2011
Functional validation of new pathways in lipoprotein metabolism identified by human geneticsRobert C Bauer, Ioannis M Stylianou, Daniel J RaderPageof 116